Sidley represented Cellomics, a leading Hong Kong-based biotech company focusing on development and commercialization of liquid biopsy products for cancer screening and early detection, in its Series B financing led by Raffles Family Office and participated by existing shareholders including the Hong Kong-listed Jacobson Pharma and the Shenzhen-listed Sinocare.
The Sidley team was led by partners Raymond Oh and Meng Ding with support from senior associate Selina Wong.
Sidley provides multidisciplinary services for life sciences clients. We advise clients across the full spectrum of their business lifecycles, ranging from formation, corporate governance, and compliance operations for start-ups, to collaboration, licensing, commercialization, and filing in the business development phase, including initial public offerings, equity financings, and bond/note issuances, as well as domestic and cross-border mergers and acquisitions, asset restructuring, equity incentive plans, and privatizations.